oppn parties Patanjali Corona Kit: False Claims To Cash-In On Health Fears

News Snippets

  • T20 WC: USA enter Super Eights as their last match against Ireland gets washed out. They were ahead of Pakistan in the points tally. Pakistan were eliminated
  • T20 WC: USA enter Super Eights as their last match against Ireland gets washed out. They were ahead of Pakistan in the points tally. Pakistan were eliminated
  • BJD leader and former Odisha CM Naveen Patnaik said that the criticism of his aide V K Pandian is "regrettable"
  • As more than 20 BJP ministers lost in the recent elections, the new Union cabinet will have many new faces from the party
  • Congress Working committee asks Rahul Gandhi to take up the position of Leader of Opposition in Lok Sabha. Gandhi says he will consider the request
  • RBI governor Shaktikanta Das said that gold was shifted to India as the quantum of RBI gold abroad had increased due to recent purchases
  • Delhi HC rules that submitting photographic evidence of adultery will not be enough, they will have to be proved as authentic in the age of deepfakes
  • A four-member panel will review NEET-UG results of 1563 candidates to check if they were given extra marks for exam time loss
  • Mamata Banerjee says her party will not join Modi's oath-taking ceremony. Also says INDIA bloc might stake claim to form government later
  • K C Tyagi of the JD(U) dropped a bombshell when he said that Nitish Kumar was offered the post of prime minister for switching sides. Opposition leaders rubbished the claim
  • This May was India's hottest month in 36 years says IMD
  • T20 WC: India take on Pakistan today. Telecast to begin at 8pm IST
  • T20 WC: Afghanistan stun New Zealand and Bangladesh win against Sri Lanka
  • T20 World Cup: Australia beat England by 36 runs. This spoils England's chances of making the playoffs as they have lost both their matches till now
  • Heat wave continues in the country as monsoon moves slow
G7 commits to promote India-Europe corridor
oppn parties
Patanjali Corona Kit: False Claims To Cash-In On Health Fears

By A Special Correspondent
First publised on 2020-06-25 13:42:45

Ramdev's Patanjali has released an ayurvedic formulation Coronil (being sold as a kit along with two other formulations, priced at Rs 545) which it claims is the first ayurvedic medicine for Covid-19. The government has asked it to stop making the erroneous claim. The Uttarakhand government has issued a clarification saying that Patanjali had applied for a license for making a medicine for boosting immunity, cough and fever which was granted to it. It also said that a notice has been issued to the company asking it to reply to why it was claiming that the drug cured Covid-19. States like Rajasthan and Maharashtra have already banned the sale of the formulation and more states are likely to do so.

It was unethical for Patanjali to make such a claim without proper trials and verification by drug bodies or the Ayush ministry of the government of India. By trying to cash in on the pandemic, Patanjali has shown that it is like other profit-minded pharma companies despite flaunting its credentials as a company rooted in making drugs as per ancient Hindu medicinal texts. It is beyond one's comprehension as to how ancient ayurveda texts could have anticipated the Covid-19 virus and prescribed a formulation to treat it. It should have promoted the drug for what it was - an immunity booster.

It is good that the Centre as well as the states have taken immediate steps to call its bluff and ask for an explanation. With citizens worried about their health due to the pandemic, such companies cannot be allowed to feed on this and fill their coffers by making false claims. Since people are trying a host of home remedies to boost immunity and since Patanjali has brand value, it is obvious that if the government does not step in to stop the sale of the dubious medicine there will be many takers for it. Patanjali should be asked to reposition the kit as one for boosting immunity and change its name before releasing it in the market.